Studies from Icahn School of Medicine at Mount Sinai in the Area of Psoriasis Reported (Once-daily Roflumilast Foam 0.3% for Scalp and Body Psoriasis: a Randomized, Double-blind, Vehicle-controlled Phase Iib Study)

Press/Media

Period	16 Apr 2024

Media coverage

Title	Studies from Icahn School of Medicine at Mount Sinai in the Area of Psoriasis Reported (Once-daily Roflumilast Foam 0.3% for Scalp and Body Psoriasis: a Randomized, Double-blind, Vehicle-controlled Phase Iib Study)
Media name/outlet	Clinical Trials Daily
Country/Territory	United States
Date	16/04/24
Persons	Leon Kircik